The nerve repair & regeneration market in Asia Pacific is expected to grow from US$ 1,266.83 million in 2022 to US$ 2,263.79 million by 2028; it is estimated to grow at a CAGR of 10.2% from 2022 to 2028.
Product Launches and Approvals to Provide Opportunities to Asia Pacific Nerve Repair & Regeneration Market Players
Several nerve repair and regeneration market players are launching various products such as internal neurostimulation devices, external neurostimulation devices, nerve conduits, nerve wraps, nerve connectors, and other biomaterials to enhance the treatment output for nerve repair and regeneration. They are also offering products such as neuromodulators, neurostimulation, and biomaterial devices. These devices are utilized for the treatment of neurodegenerative or traumatic disorders such as Parkinson's disease, Alzheimer's disease, sclerosis, multiple system atrophy, and amyotrophic lateral sclerosis. For instance, in July 2022, Checkpoint Surgical launched the Checkpoint Edge Nerve Cutting Kit, expanding the intraoperative nerve care portfolio of the company. The Checkpoint Edge Nerve Cutting Kit is the first offering in the planned portfolio of nerve-specific instruments by Checkpoint Surgical, with further expansion planned in the future. Further, in March 2022, Integra LifeSciences Holding Corporation launched the NeuraGen 3D Nerve Guide Matrix, which is a resorbable implant for the repair of peripheral nerve discontinuities. NeuraGen 3D is a nerve repair product specifically engineered to develop an optimized environment that enables a greater complete functional recovery following mid-gap nerve repair in comparison to hollow nerve conduits. In August 2021, Checkpoint Surgical, Inc. launched the NeuroShield Chitosan Nerve Wrap to expand its intraoperative nerve care product line. The NeuroShield Wrap marks the company's first product in a planned line of chitosan-based biological implants to support nerve healing. The product complements the existing product portfolio of Checkpoint Surgical, including the company’s flagship Checkpoint Nerve Stimulator/Locator, the leading nerve stimulation device for intraoperative nerve protection and repair. Thus, the active participation of market players in product innovation and development and the increase in approvals of products are likely to fuel the market growth in the coming years.
Market Overview
Asia Pacific is the fastest-growing regional market for nerve repair & regeneration. The Asia Pacific nerve repair & regeneration market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. Japan has accounted for a 30.8% share of the Asia Pacific nerve repair & regeneration market in 2021, owing to the growing incidence of nerve injuries, high prevalence of neurological disorders, rising medical tourism, and growing government support for research on neurological disorders in the country. These factors are expected to propel the Asia Pacific nerve repair & regeneration market in the coming years.
Asia Pacific Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Nerve Repair & Regeneration Market Segmentation
The Asia Pacific nerve repair & regeneration market is segmented into product and application.
Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in Asia Pacific.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,266.83 Million |
| Market Size by 2028 | US$ 2,263.79 Million |
| CAGR (2022 - 2028) | 10.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Nerve Repair & Regeneration Market is valued at US$ 1,266.83 Million in 2022, it is projected to reach US$ 2,263.79 Million by 2028.
As per our report Asia Pacific Nerve Repair & Regeneration Market, the market size is valued at US$ 1,266.83 Million in 2022, projecting it to reach US$ 2,263.79 Million by 2028. This translates to a CAGR of approximately 10.2% during the forecast period.
The Asia Pacific Nerve Repair & Regeneration Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Nerve Repair & Regeneration Market report:
The Asia Pacific Nerve Repair & Regeneration Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Nerve Repair & Regeneration Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Nerve Repair & Regeneration Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Nerve Repair & Regeneration Market
